Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Acadia Pharmaceuticals
Acadia Pharmaceuticals
Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout
Xconomy
Wed, 08/26/20 - 10:56 am
Acadia Pharmaceuticals
M&A
CerSci Therapeutics
post-surgical pain
nerve pain
2 Biotech Stocks Poised to Soar in 2020
Motley Fool
Mon, 12/30/19 - 10:32 am
Acadia Pharmaceuticals
Axsome Therapeutics
M&A
Acadia Looks to Expand Drug Beyond Parkinson’s Disease Psychosis
Xconomy
Fri, 12/6/19 - 09:28 pm
Acadia Pharmaceuticals
cilnical trials
Parkinson's Disease Psychosis
dementia-related psychosis
Top 7 Companies in Biotech Beach by Revenue
BioSpace
Thu, 12/5/19 - 10:15 am
Biotech Beach
San Diego
California
Amgen
Neurocrine
Acadia Pharmaceuticals
Retrophin
Tocagen
Mirati Therapeutics
AnaptysBio
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
ASH2019
Roche
Bristol-Myers Squibb
Acadia Pharmaceuticals
Biogen
Cassava Sciences
Alector
GW Pharma
Magenta Therapeutics
Fortress Biotech
Mustang Bio
Bluebird Bio
3 Biotech Stocks That Soared Last Week
Motley Fool
Sun, 09/15/19 - 09:51 pm
Acadia Pharmaceuticals
Nuplazid
Mesoblast
Grunenthal
MPC-06-ID
Kodiak Sciences
age-related macular degeneration
Acadia calls early halt to Nuplazid psychosis trial after promising interim results
Fierce Pharma
Tue, 09/10/19 - 11:41 pm
Acadia Pharmaceuticals
Nuplazid
dementia-related psychosis
Trial win could drive Acadia's Nuplazid to new use
Biopharma Dive
Mon, 09/9/19 - 08:00 pm
Acadia Pharmaceuticals
Nuplazid
dementia-related psychosis
clinical trials
FDA
Upcoming events – Acadia hopes for new indications for Nuplazid
EP Vantage
Fri, 05/3/19 - 10:18 am
Acadia Pharmaceuticals
antipsychotics
Nuplazid
schizophrenia
dementia
Acadia to Move Experimental Pediatric Rett Syndrome Drug to Phase 3
Xconomy
Wed, 03/27/19 - 11:41 pm
Acadia Pharmaceuticals
pediatrics
Rett Syndrome
clinical trials
trofinetide
Justice Department launches probe into Acadia's Nuplazid marketing
Fierce Pharma
Mon, 03/11/19 - 11:45 am
Acadia Pharmaceuticals
Nuplazid
DOJ
drug marketing
Follow-on roundup: Acadia raises $275M, Rocket pockets $55M
BioCentury
Thu, 11/29/18 - 12:06 am
Acadia Pharmaceuticals
Rocket Pharmaceuticals
3 Biotech Stocks That Soared This Week
Motley Fool
Sat, 09/22/18 - 05:31 pm
Viking Therapeutics
Acadia Pharmaceuticals
Corbus Pharmaceuticals
Pages
« first
‹ previous
1
2